TScan Therapeutics (TCRX)
(Delayed Data from NSDQ)
$7.32 USD
+0.03 (0.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.30 -0.02 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/08/2024
Time: -- |
3/2024 | $-0.25 | -6.58% |
Earnings Summary
For their last quarter, TScan Therapeutics (TCRX) reported earnings of -$0.21 per share, beating the Zacks Consensus Estimate of $-0.30 per share. This reflects a positive earnings surprise of 30.00%. Look out for TCRX's next earnings release expected on May 08, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 73.12%.
Earnings History
Price & Consensus
Zacks News for TCRX
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
TCRX: What are Zacks experts saying now?
Zacks Private Portfolio Services